Dr. Penza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
1st Floor
Columbus, OH 43210Phone+1 614-293-3316Fax+1 614-293-6050
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1995- Ohio State University HospitalResidency, Internal Medicine, 1989 - 1992
- Ohio State University College of MedicineClass of 1989
Certifications & Licensure
OH State Medical License 1991 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2012 Feb 09
Publications & Presentations
PubMed
- 8 citationsTherapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.Edward A. Copelan, S Hoshaw-Woodard, Patrick Elder, Sam Penza, Sherif S. Farag
Bone Marrow Transplantation. 2004-07-01 - 45 citationsMobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymp...Edward A. Copelan, Sarah K. Ceselski, S A Ezzone, L C Lasky, Sam Penza
Journal of Clinical Oncology. 1997-02-01 - 47 citationsComplement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHDSarah A Wall, Qiuhong Zhao, Martha Yearsley, Luke Blower, Akwasi Agyeman
Blood Advances. 2018-10-23
Abstracts/Posters
- Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgki...Sam Penza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell TransplantationSam Penza, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
